P2Y12 Inhibitor Adherence Patterns in Patients with Acute Coronary Syndrome

被引：0
|
作者：
Ozaki, Aya
Ko, Dennis T.
Chong, Alice
Fang, Jiming
Austin, Peter
Sud, Maneesh
Jackevicius, Cynthia A.
机构：
来源：
CIRCULATION | 2021年 / 144卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A10843
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Timing of Oral P2Y12 Inhibitor Administration in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome
    Tarantini, Giuseppe
    Mojoli, Marco
    Varbella, Ferdinando
    Caporale, Roberto
    Rigattieri, Stefano
    Ando, Giuseppe
    Cirillo, Plinio
    Pierini, Simona
    Santarelli, Andrea
    Sganzerla, Paolo
    Cacciavillani, Luisa
    Babuin, Luciano
    De Cesare, Nicoletta
    Limbruno, Ugo
    Massoni, Alberto
    Rognoni, Andrea
    Pavan, Daniela
    Belloni, Flavia
    Cernetti, Carlo
    Favero, Luca
    Saia, Francesco
    Fovino, Luca Nai
    Masiero, Giulia
    Roncon, Loris
    Gasparetto, Valeria
    Ferlini, Marco
    Ronco, Federico
    Rossini, Roberta
    Canova, Paolo
    Trabattoni, Daniela
    Russo, Alessandra
    Guiducci, Vincenzo
    Penzo, Carlo
    Tarantino, Fabio
    Mauro, Ciro
    Corrada, Elena
    Esposito, Giovanni
    Marchese, Alfredo
    Berti, Sergio
    Martinato, Matteo
    Azzolina, Danila
    Gregori, Dario
    Angiolillo, Dominick J.
    Musumeci, Giuseppe
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (21) : 2450 - 2459
  • [32] P2Y12 inhibitor monotherapy in patients undergoing percutaneous coronary intervention
    Capodanno, Davide
    Baber, Usman
    Bhatt, Deepak L.
    Collet, Jean-Philippe
    Dangas, George
    Franchi, Francesco
    Gibson, C. Michael
    Gwon, Hyeon-Cheol
    Kastrati, Adnan
    Kimura, Takeshi
    Lemos, Pedro A.
    Lopes, Renato D.
    Mehran, Roxana
    O'Donoghue, Michelle L.
    Rao, Sunil, V
    Rollini, Fabiana
    Serruys, Patrick W.
    Steg, Philippe G.
    Storey, Robert F.
    Valgimigli, Marco
    Vranckx, Pascal
    Watanabe, Hirotoshi
    Windecker, Stephan
    Angiolillo, Dominick J.
    NATURE REVIEWS CARDIOLOGY, 2022, 19 (12) : 829 - 844
  • [33] P2Y12 inhibitor monotherapy in patients undergoing percutaneous coronary intervention
    Davide Capodanno
    Usman Baber
    Deepak L. Bhatt
    Jean-Philippe Collet
    George Dangas
    Francesco Franchi
    C. Michael Gibson
    Hyeon-Cheol Gwon
    Adnan Kastrati
    Takeshi Kimura
    Pedro A. Lemos
    Renato D. Lopes
    Roxana Mehran
    Michelle L. O’Donoghue
    Sunil V. Rao
    Fabiana Rollini
    Patrick W. Serruys
    Philippe G. Steg
    Robert F. Storey
    Marco Valgimigli
    Pascal Vranckx
    Hirotoshi Watanabe
    Stephan Windecker
    Dominick J. Angiolillo
    Nature Reviews Cardiology, 2022, 19 : 829 - 844
  • [34] Changes in Treatment Patterns and Incremental Healthcare Utilization Due to P2Y12 Associated Disorders in Patients With Acute Coronary Syndrome
    Vyas, Ami
    Bash, Lori D.
    Patel, Mehul D.
    Simpson, Ross J.
    CIRCULATION, 2016, 134
  • [35] Changes in Treatment Patterns and Incremental Healthcare Utilization Due to P2Y12 Associated Disorders in Patients With Acute Coronary Syndrome
    Vyas, Ami
    Bash, Lori D.
    Patel, Mehul D.
    Simpson, Ross J.
    CIRCULATION, 2016, 134
  • [36] P2Y12 inhibitor adherence trajectories in patients with acute coronary syndrome undergoing percutaneous coronary intervention: prognostic implications (Mar, 10.1093/eurheartj/ehac116, 2022)
    Valerio, Luca
    EUROPEAN HEART JOURNAL, 2022, 43 (24) : 2285 - 2285
  • [37] Oral P2Y12 inhibiting therapy in patients with acute coronary syndrome: finding the sweet spot
    Galli, Mattia
    Ortega-Paz, Luis
    Angiolillo, Dominick J.
    EUROPEAN HEART JOURNAL, 2023, 44 (03) : 236 - 236
  • [38] Efficacy and safety of newer P2Y12 inhibitors versus clopidogrel in patients with acute coronary syndrome
    Fei, Y.
    Lam, C.
    Cheung, B.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 85 (07) : 1631 - 1631
  • [39] Impact of the Dual Antiplatelet Therapy Score on Clinical Outcomes in Acute Coronary Syndrome Patients Receiving P2Y12 Inhibitor Monotherapy
    Huang, Sheng-Wei
    Chen, Po-Wei
    Feng, Wen-Han
    Hsieh, I-Chang
    Ho, Ming-Yun
    Cheng, Chung-Wei
    Yeh, Hung-, I
    Chen, Ching-Pei
    Huang, Wei-Chun
    Fang, Ching-Chang
    Lin, Hui-Wen
    Lin, Sheng-Hsiang
    Tsai, Chin-Feng
    Su, Chun-Hung
    Li, Yi-Heng
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 8
  • [40] P2Y12 antagonists in acute coronary syndrome: In whom should they be started, and when?
    Good C.W.
    Berger P.B.
    Current Cardiology Reports, 2011, 13 (4) : 320 - 326
12345